Mbx Biosciences Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Mbx Biosciences Inc 's ROA in the second quarter of 2026?
Mbx Biosciences Inc recorded a cumulative net loss of $-104 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -20.44%.

However, within the Healthcare sector 384 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3522, from total ROA ranking in the first quarter of 2026 at 4228.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	247.04 %	84.08 %	43.42 %	41.67 %	81.41 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-104	-87	-87	-80	-77
Return On Assets (TTM)	-20.44 %	-23.58 %	-27.55 %	-28.09 %	-29.96 %
MBX's Total Ranking	# 3522	# 4228	# 3721	# 3785	# 3908
Total Assets (TTM) in million	803	453	385	400	232
Seq. Total Assets Change	77.48 %	17.54 %	-3.73 %	72.8 %	-5.86 %
Seq. Net Income Change	-	-	-	-	-

MBX's 5 Years Annual ROA >> Back to MBX Management Effectiveness >> Compare MBX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 141
Sector	# 385
Overall	# 3515

Return On Assets Statistics
High	Average	Low
-23.58 %	-27.91 %	-33.35 %
(Mar 31 2026)		(Mar 31 2025)

Financial Statements
Mbx Biosciences Inc 's Assets	$ 803 million	MBX's Balance sheet
Mbx Biosciences Inc 's Income	$ -37 million	Quarterly MBX's Income Statement
MBX's Income by Division		See MBX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	43.42 %	-	-	-	-
Total Assets in million	385	269	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-87	-62	0	0	0
Annual Return On Assets	-22.58 %	-23.06 %	-	-	-

MBX's 5 Years Annual ROA >> Back to MBX Management Effectiveness >> Compare MBX ROA to its Competitors

More Return On Assets Ratios
MBX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MBX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MBX's Competitors
Subscribers only: Roa for Mbx Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for MBX's Customers

You may also want to know
MBX's Roi	MBX's Inventory Turnover Ratio	MBX's Growth Rates	MBX's Dividend Comparisons
	MBX's Profitability Ratios	MBX's Asset Turnover Ratio	MBX's Dividend Growth
MBX's Roe	MBX's Valuation Ratios	MBX's Financial Strength Ratios	MBX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T01:20:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.